肝硬化患者肾功能模式与死亡率之间的关联
该回顾性分析纳入器官获取与移植网络登记系统中2007年7月1日至2014年7月1日等待肝移植至少90天的非状态1成人患者共22,680例,按急性肾损伤(AKI)、慢性肾病(CKD)、两者兼有或正常分组,采用竞争风险分析(以肾模式为时依协变量)关联等待list死亡率,并评估6个月死亡率的logistic回归。结果:调整包括最终MELD-Na评分在内的混杂因素后,与正常组相比,AKI合并CKD组亚风险比(SHR)2.86(95%CI 2.65-3.10)、AKI组SHR 2.42(95%CI 2.22-2.64)、CKD组SHR 1.56(95%CI 1.45-1.67)均与等待list死亡率显著相关;基于等待list登记时MELD-Na评分的曲线下面积含肾模式为0.80,不含为0.71(P < .001)。结论认为肾功能模式与肝硬化患者死亡率相关,纳入肾功能障碍类型信息可改善风险分析。
要点
- 在调整最终MELD-Na评分等混杂因素后,AKI合并CKD组等待list死亡风险约为正常组的2.86倍(SHR 2.86,95%CI 2.65-3.10)。
- AKI组等待list死亡风险约为正常组的2.42倍(SHR 2.42,95%CI 2.22-2.64),CKD组约为1.56倍(SHR 1.56,95%CI 1.45-1.67)。
- 基于等待list登记时MELD-Na评分的曲线下面积含肾模式为0.80,不含为0.71(P < .001)。
核心结论
- 在竞争风险分析中,即使调整包括最终MELD-Na评分在内的混杂因素,肾功能障碍模式仍与肝硬化患者死亡率相关。
- 纳入肾功能障碍类型信息可改善风险分析。
研究设计与样本
- 回顾性分析器官获取与移植网络登记系统中2007年7月1日至2014年7月1日等待肝移植至少90天的所有非状态1成人患者。
- 共纳入22,680例患者,按AKI、CKD、AKI合并CKD或正常分组。
- 采用竞争风险分析(以肾模式为时依协变量)关联等待list死亡率,并考虑肝移植。
- 采用logistic回归评估6个月死亡率,确定将肾功能模式纳入评估的附加获益。
主要发现
- 队列中患者等待list中位时间1.6年(范围0.7-3.1年),接受肾功能评估的中位时间5年(范围2-9年)。
- 与正常组相比,AKI合并CKD组等待list死亡SHR 2.86(95%CI 2.65-3.10),AKI组SHR 2.42(95%CI 2.22-2.64),CKD组SHR 1.56(95%CI 1.45-1.67)。
- 基于等待list登记时MELD-Na评分的曲线下面积含肾模式为0.80,不含为0.71(P < .001)。
关键数值与推荐
- AKI定义:血清肌酐在7天内或少于72天血液透析中增加≥0.3 mg/dL或≥50%。
- CKD定义:估算肾小球滤过率<60 ml/min/1.73 m2持续90天且最终估算肾小球滤过率≥30 ml/min/1.73 m2,或血液透析≥72天。
- AKI合并CKD定义:同时满足AKI和CKD定义。
- 正常定义:不满足AKI和CKD任一标准。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Renal dysfunction increases risk of death for patients with cirrhosis. We investigated whether mortality differs significantly among patients with acute kidney injury (AKI), chronic kidney disease (CKD), and both. METHODS: We performed a retrospective analysis of all non-status 1 adults on the waitlist for liver transplantation for at least 90 days, collected from the Organ Procurement and Transplantation Network registry from July 1, 2007 through July 1, 2014. We assigned patients to groups of AKI (an increase of ≥0.3 mg/dL or ≥50% in serum creatinine in the last 7 days or fewer than 72 days of hemodialysis), CKD (an estimated glomerular filtration rate <60 ml/min/1.73 m2 for 90 days with a final rate ≥30 ml/min/1.73 m2 or ≥72 days of hemodialysis), AKI and CKD (meet both definitions), or normal (meet neither definition). We performed competing risk analyses to associate patterns of renal dysfunction with waitlist mortality, accounting for liver transplantation, with renal pattern as a time-dependent covariate. Logistic regression for 6-month mortality determined the added benefit of including renal function pattern in the assessment. RESULTS: There were 22,680 patients in the cohort; they spent a median 1.6 years (range, 0.7-3.1 years) on the waitlist and a median 5 years (range, 2-9 years) undergoing assessments of renal function. In competing risk analysis, even after adjusting for confounders including final model for end-stage liver disease sodium (MELD-Na) scores, the pattern of renal function was significantly associated with waitlist mortality: AKI and CKD (subhazard ratio [SHR], 2.86; 95% CI, 2.65-3.10), AKI (SHR, 2.42; 95% CI 2.22-2.64), CKD (SHR, 1.56; 95% CI, 1.45-1.67) compared with normal. The area under the curve values, based on MELD-Na score at time of placement on the waitlist, were 0.80 with renal function pattern and 0.71 without (P < .001). CONCLUSION: In competing risk analysis, even after adjusting for confounders including final MELD-Na score, we found the pattern of renal dysfunction to associate with mortality in patients with cirrhosis. Including information on type of renal dysfunction could improve risk analysis.
引用
- Cullaro G, Verna EC, Lai JC, et al. Association Between Renal Function Pattern and Mortality in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2019. PMID: 30716479. doi:10.1016/j.cgh.2019.01.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。